Derick Chae
Psychosomatic Medicine · Honolulu, HINPI 1871709451
Payments from drug & device makers
Across 170 payments — averaging $47.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$2K
- Alkermes, Inc.$1K
- Neurocrine Biosciences, Inc.$752
- Otsuka America Pharmaceutical, Inc.$686
- Sunovion Pharmaceuticals Inc.$657
- Johnson & Johnson$558
- plus $2K from 9 others
What the payments were for
- Food & beverage$7,94299%
- Education$501%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 35 | $2,301 |
| Alkermes, Inc. | 24 | $1,062 |
| Neurocrine Biosciences, Inc. | 13 | $752 |
| Otsuka America Pharmaceutical, Inc. | 19 | $686 |
| Sunovion Pharmaceuticals Inc. | 25 | $657 |
| Johnson & Johnson | 14 | $558 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $489 |
| Axsome Therapeutics, Inc. | 3 | $358 |
| AbbVie | 3 | $339 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $213 |
| Lundbeck LLC | 8 | $179 |
| Neuronetics, Inc. | 1 | $141 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $127 |
| Jazz Pharmaceuticals Inc. | 1 | $116 |
| Eisai Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$1,314
- ARISTADA$981
- Austedo XR$718
- UZEDY$617
- AUSTEDO$606
- INGREZZA$604
- CAPLYTA$382
- Auvelity$358
- VRAYLAR$339
- SPRAVATO$250
- REXULTI$246
- ARISTADA INITIO$245
- LATUDA$233
- NEUROSTAR TMS THERAPY$141
- ABILIFY ASIMTUFII$127
- INVEGA SUSTENNA$125
- XYREM$116
- ABILIFY MAINTENA$112
How this compares
Too few psychosomatic medicine providers in Hawaiito place this figure against a meaningful peer group, so we don't.
Other psychosomatic medicine in Honolulu
- Mark BernsteinKapolei$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.